These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2062765)

  • 1. Serious bacterial infections in children. When can outpatient treatment be used?
    Gordon P
    Postgrad Med; 1991 Jul; 90(1):87-90. PubMed ID: 2062765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of long half-life parenteral cephalosporins in ambulatory practice.
    Sauerwein M; Deamer RL; Prichard JG
    J Fam Pract; 1987 Jan; 24(1):47-51. PubMed ID: 3794613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outpatient treatment of serious community-acquired pediatric infections using once daily intramuscular ceftriaxone.
    Dagan R; Phillip M; Watemberg NM; Kassis I
    Pediatr Infect Dis J; 1987 Dec; 6(12):1080-4. PubMed ID: 3324038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Once-daily ceftriaxone in the outpatient treatment of paediatric infections.
    Bradley JS
    Chemotherapy; 1991; 37 Suppl 3():3-6. PubMed ID: 1884651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outpatient treatment of febrile infants 28 to 89 days of age with intramuscular administration of ceftriaxone.
    Baskin MN; O'Rourke EJ; Fleisher GR
    J Pediatr; 1992 Jan; 120(1):22-7. PubMed ID: 1731019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Otolaryngology and infectious disease team approach for outpatient management of serious pediatric infections requiring parenteral antibiotic therapy.
    Einhorn M; Fliss DM; Leiberman A; Dagan R
    Int J Pediatr Otorhinolaryngol; 1992 Nov; 24(3):245-51. PubMed ID: 1399313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Once-daily intramuscular ceftriaxone in the outpatient treatment of severe community-acquired pneumonia in children.
    Leibovitz E; Tabachnik E; Fliedel O; Steinberg S; Miskin A; Askenazi A; Barak Y
    Clin Pediatr (Phila); 1990 Nov; 29(11):634-9. PubMed ID: 2265514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceftriaxone in treatment of serious infections. Skin and soft tissue infections.
    Gainer RB
    Hosp Pract (Off Ed); 1991 Sep; 26 Suppl 5():24-30; discussion 55-7. PubMed ID: 1918219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of various infections in an outpatient practice by intramuscular ceftriaxone: home parenteral therapy.
    Karachalios GN; Georgiopoulos AN; Kanatakis S
    Chemotherapy; 1989; 35(5):389-92. PubMed ID: 2676406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nurse-led management of uncomplicated cellulitis in the community: evaluation of a protocol incorporating intravenous ceftriaxone.
    Seaton RA; Bell E; Gourlay Y; Semple L
    J Antimicrob Chemother; 2005 May; 55(5):764-7. PubMed ID: 15772137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serious pediatric infections.
    Kaplan SL
    Am J Med; 1990 Apr; 88(4A):18S-24S. PubMed ID: 2183605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Once-daily administration of ceftriaxone for the treatment of selected serious bacterial infections in children.
    Frenkel LD
    Pediatrics; 1988 Sep; 82(3 Pt 2):486-91. PubMed ID: 3405685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic treatment for urinary tract infections in pediatric patients.
    Hellerstein S
    Minerva Pediatr; 2003 Oct; 55(5):395-406. PubMed ID: 14608263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric intramuscular injections: do you know the procedure and complications?
    Losek JD; Gyuro J
    Pediatr Emerg Care; 1992 Apr; 8(2):79-81. PubMed ID: 1603705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ceftriaxone: an update of its use in the management of community-acquired and nosocomial infections.
    Lamb HM; Ormrod D; Scott LJ; Figgitt DP
    Drugs; 2002; 62(7):1041-89. PubMed ID: 11985490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial chemotherapy for treatment of infections in outpatient surgery.
    Flesch R
    Eur Surg Res; 1989; 21 Suppl 1():52-4. PubMed ID: 2737216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Place of parenteral cephalosporins in the ambulatory setting: clinical evidence.
    Nathwani D
    Drugs; 2000; 59 Suppl 3():37-46; discussion 47-9. PubMed ID: 10845412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ceftriaxone-related agranulocytosis during outpatient parenteral antibiotic therapy.
    Duncan CJ; Evans TJ; Seaton RA
    J Antimicrob Chemother; 2010 Nov; 65(11):2483-4. PubMed ID: 20810422
    [No Abstract]   [Full Text] [Related]  

  • 19. Ambulatory intravenous antibiotic therapy for children with preseptal cellulitis.
    Brugha RE; Abrahamson E
    Pediatr Emerg Care; 2012 Mar; 28(3):226-8. PubMed ID: 22344208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. European Surveillance of Antimicrobial Consumption (ESAC): outpatient cephalosporin use in Europe (1997-2009).
    Versporten A; Coenen S; Adriaenssens N; Muller A; Minalu G; Faes C; Vankerckhoven V; Aerts M; Hens N; Molenberghs G; Goossens H;
    J Antimicrob Chemother; 2011 Dec; 66 Suppl 6():vi25-35. PubMed ID: 22096063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.